Rigel Pharmaceuticals Inc Investor and Analyst Call Transcript
Greeting and welcome to Rigel Pharmaceuticals' Investor and Analyst Conference Call (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce our first speaker, Dolly Vance, who is Rigel's Executive Vice President, Corporate Affairs and General Counsel. Thank you, Ms. Vance, you may begin.
Welcome to Rigel's Investor and Analyst Conference Call. We have posted the accompanying presentation for today's call in the Event section on our Investor Relations page on our website at www.rigel.com. As a reminder, during today's call, we may make forward-looking statements. These statements are subject to risks and uncertainties that may cause the actual results to differ from those forecasted. A discussion of these risks can be found in our most recent quarterly report on Form 10-Q on file with the SEC. Any forward-looking statements are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |